BML Capital Management, LLC - MILESTONE PHARMACEUTICALS IN ownership

MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
BML Capital Management, LLC ownership history of MILESTONE PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$844,750
+8.8%
272,5000.0%0.78%
+11.0%
Q2 2023$776,625
-10.4%
272,500
+23.9%
0.70%
-6.7%
Q1 2023$866,800
+21.6%
220,000
+22.2%
0.75%
+10.0%
Q4 2022$712,800180,0000.68%
Other shareholders
MILESTONE PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Ikarian Capital, LLC 1,750,043$11,464,0001.71%
Novo Holdings A/S 2,530,585$16,575,0000.78%
Boxer Capital, LLC 2,238,861$14,665,0000.57%
RTW INVESTMENTS, LP 4,315,102$28,264,0000.41%
RA Capital Management 2,246,503$14,715,0000.26%
Bleichroeder LP 250,000$1,638,0000.26%
PURA VIDA INVESTMENTS, LLC 931,511$6,101,0000.22%
Orbimed Advisors 2,583,821$16,924,0000.22%
SUVRETTA CAPITAL MANAGEMENT, LLC 851,291$5,576,0000.11%
Eversept Partners, LP 147,165$963,9310.06%
View complete list of MILESTONE PHARMACEUTICALS IN shareholders